Lipid abnormalities in patients infected by the human immunodeficiency virus. A pathogenic hypotesis;Alteraciones del metabolismo de los lipidos en los pacientes infectados por el virus de la inmunodeficiencia humana. Una hipotesis acerca de su patogenia

Medicina Clinica

Volumn 115, Issue 4, 2000, Pages 145-150

  Rodriguez Vidigal, F F ^a   Munoz Sanz, A ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR; CYTOCHROME P450; GLUCOSE TRANSPORTER; INTERLEUKIN 1; LAMIVUDINE; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NUCLEOSIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEINASE INHIBITOR; RETINOIC ACID BINDING PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TUMOR NECROSIS FACTOR;

DIET; EXERCISE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID METABOLISM; REVIEW;

EID: 0034709542     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71490-4     Document Type: Review

References (77)

1. Hypertriglyceridemia in the acquired immunodeficiency syndrome
2. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome
3. Dislipemia e infeccion por VIH-1 en adictos a drogas intravenosas
4. Multiple symmetrical lipomatosis associated with protease inhibitors
5. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance due to HIV protease inhibitors
6. Visceral abdominal-fat accumulation associated with use of indinavir
7. <> in men with HIV-1 infection
8. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired glucose tolerance in HIV-infected patients
9. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
10. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort study
11. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long term nucleoside analogue therapy
12. Monogenic disorders of obesity and body fat distribution
13. Interferons and tumor necrosis factors have similar catabolic effects on 3T3-L1 cells
14. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
15. Evidence for two classes of cytokines that simulate hepatic lipogenesis: Relationships among tumor necrosis factor, interleukin-1 and interferon-alpha
16. Circulating Interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
17. Altered concentrations of appetite regulators may contribute to development and maintenance of HIV-associated wasting
18. Resting energy expenditure es increased in stable, malnourished HIV-infected patients
19. Energy expenditure and wasting in human immunodeficiency virus infection
20. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy
21. Loss of lean body mass correlates with androgen levels in hypogonadal men with AIDS wasting
22. Body composition and endocrine function in women with AIDS wasting
23. The effect of protease inhibitors on weight and body composition in HIV-infected patients
24. Plasma fatty acids levels in patients with acquired immune deficiency syndrome and controls
25. The esterified plasma fatty acid profile is altered in early HIV-1 infection
26. Long-chain polyunsaturated fatty acids in children with severe protein-energy malnutrition with and without human immunodeficiency virus-1 infection
27. Omega-3 polyunsaturated fatty acids as evolutive marker in HIV-1 infection
28. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function
29. Membrane lipid modification and immune function
30. Membrane lipid composition and cellular function
31. Omega-3 fatty acids in health and disease and growth and development
32. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells
33. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
34. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet
35. Dietary influences on serum lipids and lipoproteins
36. Effect of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women
37. The relationship between alcohol and coronary heart disease: Is there a protective effect?
38. Triglyceride-lowering effect of marine polyunsaturateds in patients with hypertriglyceridemia
39. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia
40. Effects or dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects
41. Eating disorders
42. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
43. Mitochondrial toxicity induced by nucleoside analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
44. Mitochondrial myopathy caused by long-term zidovudine toxicity
45. Beta3-adrenoceptor: An update
46. The beta3-adrenergic receptor - A cause and cure of obesity?
47. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3-adrenergic-receptor gene
48. Multiple symmetric lipomatosis: A defect in adrenergic-stimulated lipolysis
49. Mitochondrial dysfunction in multiple symmetrical lipomatosis
50. Multiple symmetric lipomatosis: Abnormalities in complex IV and multiple deletions in mitochondrial DNA
51. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
52. Glucose transporters and insulin action
53. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities
54. A pilot study of exercise training to recue trunk fat in adults with HIV-associated fat redistribution